Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Wei-neng Feng"'
Autor:
Yi‐Long Wu, Shun Lu, Ying Cheng, Qing Zhou, Hai‐Yan Tu, Qing‐Hua Zhou, Lv‐Hua Wang, Li Zhang, Jian‐Ying Zhou, Cheng Huang, Ming Chen, Cheng‐Ping Hu, Shao‐Kun Chuai, Xiao‐Nan Wang, Xiao‐Qing Liu, Ji‐Wei Liu, Peng‐Hui Zhou, Wei‐Zhi Chen, Ling‐Hua Yan, Yun‐Peng Liu, An‐Wen Liu, Xu‐Chao Zhang, Hui Li, Rong‐Rong Chen, Dong‐Mei Lin, Cong‐Ying Xie, Zheng‐Fei Zhu, Hui‐Ying Liang, Yong Song, Xiao‐Rong Dong, Ming‐Fang Zhao, Gui‐Bin Qiao, Jiu‐Wei Cui, Zi‐Ming Li, Zhi‐Jie Wang, Xiao‐Yuan Chen, Nong Yang, Gen Lin, Pan‐Wen Tian, Yun Fan, Qi‐Bin Song, Yuan Chen, Jian‐Chun Duan, Jia‐Lei Wang, Bo Zhu, Bu‐Hai Wang, Jun Zhao, Qi‐Tao Yu, Li‐Feng Wang, Hai‐Bo Zhang, Jie Hu, Rui Ma, Tong‐Mei Zhang, Jie Lin, Qian Chu, Sheng‐Xiang Ren, Yu Yao, Lin Wu, Hui‐Juan Wang, Fang Wu, Wen‐Zhao Zhong, Yi Hu, Ke‐Neng Chen, Jian Zhao, Fan Yang, Qun Wang, Dong‐Sheng Yue, Jian‐Ya Zhou, Peng Shen, Jia‐Tao Zhang, Xiao‐Long Yan, Mei‐Juan Huang, Wei‐Neng Feng, Li Li, Chinese Association of Lung Cancer, Guangdong Association of Clinical Trials (GACT)/Chinese Thoracic Oncology Group (CTONG)
Publikováno v:
Medicine Advances, Vol 1, Iss 4, Pp 293-305 (2023)
Abstract The importance of uncommon/rare oncogenic drivers in non‐small cell lung cancer (NSCLC) was underscored during the 20th China Lung Cancer Summit. These drivers, while present in a significant proportion of NSCLC patients, remain a challeng
Externí odkaz:
https://doaj.org/article/6cf86ef452334af4a74e37fd66750545
Autor:
Ning Zhao, Zhuo-peng Wu, Jie Yang, Wei-neng Feng, Sheng-li Yang, Ying Luo, Jun Ye, Fei Wang, Xiao-wen Zhang, Ye Xiao, Ling-ling Wu, Wei-quan Gu
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-10 (2023)
Abstract Background The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is still under investigation as adjuvant treatment for early-stage disease. Here, we performed a meta-analysis to evaluate the efficacy of adjuvant EGFR
Externí odkaz:
https://doaj.org/article/348dc3b56f0549a18b0c311a20d6e1d4
Autor:
Zhen Wang, Xu-Chao Zhang, Wei-Neng Feng, Li Zhang, Xiao-Qing Liu, Wei-Bang Guo, Yan-Ming Deng, Qing-Feng Zou, Jin-Ji Yang, Qing Zhou, Bin-Chao Wang, Hua-Jun Chen, Hai-Yan Tu, Hong-Hong Yan, Yi-Long Wu
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Circulating tumor cells (CTCs) are prognostic biomarker in non-small-cell lung cancer (NSCLC). CTCs could also be used as predictor of efficacy of systemic treatments in advanced NSCLC. Objectives: We described the dynamic changes of CTCs
Externí odkaz:
https://doaj.org/article/3d41e67e02a8435983d78956b0f52623
Autor:
Wei-neng Feng, Wei-quan Gu, Ning Zhao, Ying-ming Pan, Wei Luo, Hua Zhang, Jian-miao Liang, Jie Yang, Yan-ming Deng
Publikováno v:
Translational Oncology, Vol 11, Iss 2, Pp 542-545 (2018)
BACKGROUND: Liquid biopsy is emerging as an important approach for tumor genotyping in non-small cell lung cancer, ddPCR and SuperARMS are both methods with high sensitivity and specificity for detecting EGFR mutation in plasma. We aimed to compare d
Externí odkaz:
https://doaj.org/article/3ad27949baa5495f8f8d3aa774d5603a
Autor:
Fu-He Hsiao, Cheng-Chu Chung, Chun-Hao Chiang, Wei-Neng Feng, Wen-Yen Tzeng, Hung-Min Lin, Chien-Ming Tu, Heng-Liang Wu, Yu-Han Wang, Wei-Yen Woon, Hsiao-Chien Chen, Ching-Hsiang Chen, Chao-Yuan Lo, Man-Hong Lai, Yu-Ming Chang, Li-Syuan Lu, Wen-Hao Chang, Chun-Wei Chen, Chih-Wei Luo
Publikováno v:
ACS Nano. 16:4298-4307
Autor:
Zai‐yi Liu, Zhu Liang, Yu Zongqiao, Chao Zhang, Shao-hong Huang, Yi-Long Wu, Xing Sun, Jie Qin, Feiyue Huang, Wen-Zhao Zhong, Yan‐bin Zhang, Wei-Neng Feng, Xue-Ning Yang, Xiaowei Guo, Qing Zhou, Chang Jia, Xing‐lin Gao, Tao Zhou, Yun‐sheng Wu, Xuegong Zhang, Ming‐fang Zhao, Ke Li, Kang Dang, Wei‐jun Fang
Publikováno v:
The Oncologist. 24:1159-1165
Background Computed tomography (CT) is essential for pulmonary nodule detection in diagnosing lung cancer. As deep learning algorithms have recently been regarded as a promising technique in medical fields, we attempt to integrate a well-trained deep
Autor:
Wei-neng Feng, Weiguang Gu, Hua Zhang, Yiyu Lu, Weiquan Gu, Minjing Li, Shuang Yang, Zhi-Jian Ye, Jian Liu, Qing Lin, Yaojun Liang, Haiming Chen, Xiaoliang Shi, Dong You
Publikováno v:
Journal of Clinical Oncology. 40:e15032-e15032
e15032 Background: EGFR is a major oncogene in non-small cell lung cancer (NSCLC) patients. Although EGFR tyrosine kinase inhibitors (TKIs) have effectively improved the survival of NSCLC patients, acquired drug resistance is a critical clinical chal
Autor:
Fu-He Hsiao, Cheng-Chu Chung, Chun-Hao Chiang, Wei-Neng Feng, Wen-Yen Tzeng, Hung-Min Lin, Chien-Ming Tu, Heng-Liang Wu, Yu-Han Wang, Wei-Yen Woon, Hsiao-Chien Chen, Ching-Hsiang Chen, Chao-Yuan Lo, Man-Hong Lai, Yu-Ming Chang, Li-Syuan Lu, Wen-Hao Chang, Chun-Wei Chen, Chih-Wei Luo
Publikováno v:
ACS Nano; 3/22/2022, Vol. 16 Issue 3, p4298-4307, 10p
Autor:
Guorong Zou, Xiong Zou, Guo Li, Zhigang Liu, Shan Jiang, Jin Gao, Lei Cui, Yu-Xiang He, Chenghui Huang, Wei Yi, Ming-Yuan Chen, Hualin Chen, Jie Tang, Yuling Zhou, Wei-neng Feng, Lin Xiao, Guang Han, Lemeng Zhang, Qun Zhang, Shuang Yang
Publikováno v:
Journal of Clinical Oncology. 39:TPS12133-TPS12133
TPS12133 Background: Chemotherapy-induced nausea and vomiting (CINV) is a common side effect of cancer treatments, and dexamethasone offers an advantage over placebo for protection against chemotherapy-induced emesis in both acute and delayed phases.
Autor:
Li Lin, Wei Neng Feng, Zhe Li Huang, Xiu Yu Cai, Tao Xu, Yong Feng Wu, Guo Yi Zhang, Wei Hong Wei, Yan Ming Deng, Qiu Xia Lu
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 13:785-789
Background and Purpose: Cisplatin is the most common chemotherapeutic agent for loco-regionally advanced nasopharyngeal carcinoma (NPC); however, toxicity is a limiting factor for some patients. We retrospectively compared the efficacy and toxicity o